116 related articles for article (PubMed ID: 27084522)
1. Proton pump inhibitors induce a caspase-independent antitumor effect against human multiple myeloma.
Canitano A; Iessi E; Spugnini EP; Federici C; Fais S
Cancer Lett; 2016 Jul; 376(2):278-83. PubMed ID: 27084522
[TBL] [Abstract][Full Text] [Related]
2. Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma.
Azzarito T; Venturi G; Cesolini A; Fais S
Cancer Lett; 2015 Jan; 356(2 Pt B):697-703. PubMed ID: 25449440
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.
Lim YJ; Phan TM; Dial EJ; Graham DY; Lichtenberger LM
Digestion; 2012; 86(2):171-7. PubMed ID: 22907267
[TBL] [Abstract][Full Text] [Related]
4. Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors.
Yu M; Lee C; Wang M; Tannock IF
Cancer Sci; 2015 Oct; 106(10):1438-47. PubMed ID: 26212113
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.
Zvyaga T; Chang SY; Chen C; Yang Z; Vuppugalla R; Hurley J; Thorndike D; Wagner A; Chimalakonda A; Rodrigues AD
Drug Metab Dispos; 2012 Sep; 40(9):1698-711. PubMed ID: 22648560
[TBL] [Abstract][Full Text] [Related]
6. The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel.
Ogilvie BW; Yerino P; Kazmi F; Buckley DB; Rostami-Hodjegan A; Paris BL; Toren P; Parkinson A
Drug Metab Dispos; 2011 Nov; 39(11):2020-33. PubMed ID: 21795468
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole, lansoprazole and pantoprazole had no effect on blood pressure and electrocardiogram of anesthetized rat.
Yenişehirli A; Naseri E
Pharmacol Res; 2008 Jul; 58(1):65-71. PubMed ID: 18647653
[TBL] [Abstract][Full Text] [Related]
8. The Evaluation of Potential Cytotoxic Effect of Different Proton Pump Inhibitors on Different Human Cancer Cell Lines.
Qasem A; Kasabri V; AbuRish E; Bustanji Y; Al-Hiari Y; Al-Abbasi R; Abu-Irmaileh B; Alalawi S
Anticancer Agents Med Chem; 2020; 20(2):245-253. PubMed ID: 31663482
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect.
Lugini L; Federici C; Borghi M; Azzarito T; Marino ML; Cesolini A; Spugnini EP; Fais S
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):538-45. PubMed ID: 26018420
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of omeprazole and lansoprazole enantiomers on aryl hydrocarbon receptor in human hepatocytes and cell lines.
Novotna A; Srovnalova A; Svecarova M; Korhonova M; Bartonkova I; Dvorak Z
PLoS One; 2014; 9(6):e98711. PubMed ID: 24887303
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole Exacerbates Pemetrexed-Mediated Hematologic Toxicity by Competitive Inhibition of Renal Basolateral Human Organic Anion Transporter 3.
Ikemura K; Hamada Y; Kaya C; Enokiya T; Muraki Y; Nakahara H; Fujimoto H; Kobayashi T; Iwamoto T; Okuda M
Drug Metab Dispos; 2016 Oct; 44(10):1543-9. PubMed ID: 27465369
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of combination of the inhibitors of two new oncotargets: proton pumps and reverse transcriptase.
Lugini L; Sciamanna I; Federici C; Iessi E; Spugnini EP; Fais S
Oncotarget; 2017 Jan; 8(3):4147-4155. PubMed ID: 27926505
[TBL] [Abstract][Full Text] [Related]
13. Effect of esomeprazole with/without acetylsalicylic acid, omeprazole and lansoprazole on pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
Andersson T; Nagy P; Niazi M; Nylander S; Galbraith H; Ranjan S; Wallentin L
Am J Cardiovasc Drugs; 2014 Jun; 14(3):217-27. PubMed ID: 24677117
[TBL] [Abstract][Full Text] [Related]
14. Effect of proton pump inhibitors on voriconazole concentrations in Chinese patients with malignant hematological diseases.
Huang Q; Liu Q; Yin T; Hu L; Ding H; Liu S; Jiang Y
Eur J Clin Pharmacol; 2020 Jun; 76(6):833-842. PubMed ID: 32157329
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity.
Hashioka S; Klegeris A; McGeer PL
Exp Neurol; 2009 May; 217(1):177-83. PubMed ID: 19232345
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors omeprazole, lansoprazole and pantoprazole induce relaxation in the rat lower oesophageal sphincter.
Yurtsever AS; Pektas M; Ozkur M; Un I; Erenmemisoglu A; Buyukafsar K
J Pharm Pharmacol; 2011 Oct; 63(10):1295-300. PubMed ID: 21899545
[TBL] [Abstract][Full Text] [Related]
17. Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer.
Yeo M; Kim DK; Park HJ; Cho SW; Cheong JY; Lee KJ
Cancer Sci; 2008 Jan; 99(1):185. PubMed ID: 18224727
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.
De Milito A; Iessi E; Logozzi M; Lozupone F; Spada M; Marino ML; Federici C; Perdicchio M; Matarrese P; Lugini L; Nilsson A; Fais S
Cancer Res; 2007 Jun; 67(11):5408-17. PubMed ID: 17545622
[TBL] [Abstract][Full Text] [Related]
19. A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
Frelinger AL; Lee RD; Mulford DJ; Wu J; Nudurupati S; Nigam A; Brooks JK; Bhatt DL; Michelson AD
J Am Coll Cardiol; 2012 Apr; 59(14):1304-11. PubMed ID: 22464259
[TBL] [Abstract][Full Text] [Related]
20. Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
Zhao F; Wang J; Yang Y; Wang X; Shi R; Xu Z; Huang Z; Zhang G
Helicobacter; 2008 Dec; 13(6):532-41. PubMed ID: 19166419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
